MedTrace Logo

Difference of Gastric Microbiota in the Process of Correa's Model.

NCT02833363 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-26

No results posted yet for this study

Summary

Helicobater pylori plays an important role in the development of gastric cancer. Eradication therapy can reducing the morbidity of gastric cancer, but can't totally prevent it especially when atrophy and more serious precancerous lesions already happened. Prior studies found the gastric bacterial difference among gastritis, intestinal metaplasia and gastric cancer. However, they didn't reach an agreement. Correa's model is widely accepted in the development of gastric cancer. The pathological change makes a more suitable environment for bacteria to overgrowth. This study are designed to analyze the gastric microbial difference of non-atrophic gastritis, atrophic gastritis, intestinal metaplasia, intraepithelial neoplasia and gastric cancer.

Conditions

  • Gastric Microbiota
  • Non-atrophic Gastritis
  • Atrophic Gastritis
  • Intestinal Metaplasia
  • Intraepithelial Neoplasia
  • Gastric Cancer
  • Helicobacter Pylori

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, MD,PHD · Qilu Hospital of Shandong University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-12-31
Completion
2017-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833363 on ClinicalTrials.gov